Chambers Review
Provided by Chambers
Contact number
+1 202 637 5600Provided by Hogan Lovells
We know how overwhelming it can be trying to effectively navigate today’s regulatory environment and capitalize on strategic opportunities. Many members of our team have previously worked in key positions in both the private and public sectors, including the U.S. Department of Health and Human Services (HHS), the Centers for Medicare & Medicaid Services (CMS), and the Federal Trade Commission (FTC).
Having an in-depth understanding of the relationship between the government and global health care marketplace allows us to counsel you effectively on legal and regulatory issues — and to be your strategic advisor, litigator, and dealmaker, too.
Provided by Chambers
Hogan Lovells US LLP successfully represented Danco Laboratories in a lawsuit seeking to revoke the FDA's approval of Danco's product Mifeprex, a drug approved to medically terminate pregnancy.
Provided by Chambers
Hogan's department is distinguished by its exceptional expertise, responsiveness and commitment to understanding clients' needs. The team excels at integrating legal strategy with business objectives.
Hogan Lovells has deep, substantive experience and access to regulators. The firm is very plugged in to the industry and evolving issues.
The Hogan team provides practical and risk-based advice as well as flexibility and efficiency.
The Hogan team not only have several former FDA staff members but also possess significant scientific and technical expertise. They are always responsive and get the job done quickly and efficiently.
The team provide dependable excellence, deep subject matter expertise and an ability to be thought partners. They have earned a superior reputation and the trust of peers in the industry.
Hogan's department is distinguished by its exceptional expertise, responsiveness and commitment to understanding clients' needs. The team excels at integrating legal strategy with business objectives.
Hogan Lovells has deep, substantive experience and access to regulators. The firm is very plugged in to the industry and evolving issues.
The Hogan team provides practical and risk-based advice as well as flexibility and efficiency.
The Hogan team not only have several former FDA staff members but also possess significant scientific and technical expertise. They are always responsive and get the job done quickly and efficiently.
The team provide dependable excellence, deep subject matter expertise and an ability to be thought partners. They have earned a superior reputation and the trust of peers in the industry.
Provided by Chambers
Jonathan is fantastic; he is extremely knowledgeable, practical and easy to understand in a space which can be really convoluted. He helps move things along and has a great relationship with the FDA.
David is top-notch. He just has exceptional judgment and really wonderful writing skills. He is a preeminent expert.
Jonathan Diesenhaus of Hogan Lovells US is notable for his impressive healthcare litigation practice. He is a strong choice for hospitals facing complex disputes, and regularly takes on sophisticated FCA litigation.
Jonathan is knowledgeable and cool under pressure. He is very responsive, always reachable and terrific.
Philip Katz of Hogan Lovells US LLP is well noted for his expertise in an array of FDA matters. He has strength in issues relating to orphan drugs designation and regulatory exclusivity.
Beth is up to date on trends and challenges and she can inform you to make a good decision. She really goes above and beyond to make sure everyone is well aware of the choices.
Beth is one of the most experienced and trusted attorneys in the country when it comes to matters involving Medicare coverage and reimbursement for medical technology.
Beth combines political savviness with deep policy expertise. She has an ability to cut through complex problems and formulate coherent and compelling messages customized to resonate with CMS staff.
David has great depth of knowledge and significant scientific expertise. He provides insightful and thorough advice and is well respected by agency personnel.
David's communication is efficient and timely. He meets the needs and he worked seamlessly and effectively.
I can trust that Michael will provide timely, practical and informed advice in a right-sized manner.
Michael is so knowledgeable in a niche space. His intellect is his strength. He understands risk tolerance and has a strong sense of where agencies are focusing, which provides predictability.
Alice is an absolute expert in price reporting issues. She is always available to address complex issues in a way that makes it practical for us to devise strategies and weave through difficult areas.
Alice is very practical and gives great advice.
Meredith Manning comes highly recommended for her longstanding regulatory expertise, which sees her regularly work with a range of pharmaceuticals. She is equally adept at providing compliance counsel and advising on investigations conducted by entities such as the FDA.
Meredith has been amazing. She is doing cutting-edge legal work and is really helpful, amazing and ground-breaking.
Ronald gives very good, practical guidance and knows what he is doing.
Ronald's industry knowledge is invaluable.
Lynn Mehler of Hogan Lovells US LLP handles a range of FDA regulatory matters for pharmaceutical clients, from approvals to risk evaluation strategies.
Lynn's knowledge of how the FDA works and representation of many parties in this area gives her a perspective that no one else has.
Provided by Hogan Lovells
Provided by Hogan Lovells
Digital Health